These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Management of Lobular Neoplasia Diagnosed by Core Biopsy. Jani C; Lotz M; Keates S; Gupta Y; Walker A; Al Omari O; Parvez A; Patel D; Gnata M; Perry J; Khorashadi L; Weissmann L; Pories SE Breast J; 2023; 2023():8185446. PubMed ID: 37114120 [TBL] [Abstract][Full Text] [Related]
24. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ. Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065 [TBL] [Abstract][Full Text] [Related]
25. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Cangiarella J; Guth A; Axelrod D; Darvishian F; Singh B; Simsir A; Roses D; Mercado C Arch Pathol Lab Med; 2008 Jun; 132(6):979-83. PubMed ID: 18517282 [TBL] [Abstract][Full Text] [Related]
26. Should the extent of lobular neoplasia on core biopsy influence the decision for excision? Esserman LE; Lamea L; Tanev S; Poppiti R Breast J; 2007; 13(1):55-61. PubMed ID: 17214794 [TBL] [Abstract][Full Text] [Related]
27. Lobular carcinoma in situ on core biopsy-what is the clinical significance? O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699 [TBL] [Abstract][Full Text] [Related]
28. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Renshaw AA; Gould EW Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205 [TBL] [Abstract][Full Text] [Related]
29. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast]. Li HY; Ren GS; Arnould N; Brettes JP Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828 [TBL] [Abstract][Full Text] [Related]
30. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA; Derhagopian RP; Martinez P; Gould EW Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [TBL] [Abstract][Full Text] [Related]
31. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q; Montemezzi S; D'Atri C Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [TBL] [Abstract][Full Text] [Related]
32. Management of patients diagnosed with lobular carcinoma in situ at needle core biopsy at a community-based outpatient facility. Destounis SV; Murphy PF; Seifert PJ; Somerville PA; Arieno AL; Morgan RC; Young WL AJR Am J Roentgenol; 2012 Feb; 198(2):281-7. PubMed ID: 22268169 [TBL] [Abstract][Full Text] [Related]
33. Correlation between core biopsy and excisional biopsy in breast high-risk lesions. Margenthaler JA; Duke D; Monsees BS; Barton PT; Clark C; Dietz JR Am J Surg; 2006 Oct; 192(4):534-7. PubMed ID: 16978969 [TBL] [Abstract][Full Text] [Related]
34. Observation versus excision of lobular neoplasia on core needle biopsy of the breast. Schmidt H; Arditi B; Wooster M; Weltz C; Margolies L; Bleiweiss I; Port E; Jaffer S Breast Cancer Res Treat; 2018 Apr; 168(3):649-654. PubMed ID: 29299726 [TBL] [Abstract][Full Text] [Related]
35. Outcomes of classic lobular neoplasia diagnosed on breast core needle biopsy: a retrospective multi-center study. Genco IS; Tugertimur B; Chang Q; Cassell L; Hajiyeva S Virchows Arch; 2020 Feb; 476(2):209-217. PubMed ID: 31776645 [TBL] [Abstract][Full Text] [Related]
36. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852 [TBL] [Abstract][Full Text] [Related]
37. Clinical importance of histologic grading of lobular carcinoma in situ in breast core needle biopsy specimens: current issues and controversies. Gao F; Carter G; Tseng G; Chivukula M Am J Clin Pathol; 2010 May; 133(5):767-71. PubMed ID: 20395524 [TBL] [Abstract][Full Text] [Related]
38. Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision. Laws A; Katlin F; Nakhlis F; Chikarmane SA; Schnitt SJ; King TA Ann Surg Oncol; 2022 Mar; 29(3):1660-1667. PubMed ID: 34554341 [TBL] [Abstract][Full Text] [Related]
39. Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target. D'Alfonso TM; Wang K; Chiu YL; Shin SJ Arch Pathol Lab Med; 2013 Jul; 137(7):927-35. PubMed ID: 23808465 [TBL] [Abstract][Full Text] [Related]
40. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Shin SJ; Rosen PP Arch Pathol Lab Med; 2002 Jun; 126(6):697-701. PubMed ID: 12033958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]